Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Sadie Khwaja, Balasubrahmanyam Kumar, Carl Philpott, David P. Strachan

Research output: Other contribution

863 Citations (Scopus)
Original languageEnglish
TypeSupplementary Materials
Media of outputpdf
Number of pages56
Publication statusPublished - Nov 2019

Cite this